logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9254261 B1

PDFFull Text
Expired
Date of Patent:
Feb. 09, 2016

Filed:

Mar. 03, 2014

Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid

Applicant:

Sandoz Ag, Basel, CH;

Inventors:

Rok Staric, Duplje, SI;

Marko Oblak, Ljubljana, SI;

Tanja Rozman Peterka, Ljubjana, SI;

Veronika Debevec, Polhov Gradec, SI;

Assignee:

Sandoz AG, , CH;

Attorney:

Luedeka Neely Group, P.C.

Primary Examiner:

My-Chau T Tran

Int. Cl.
CPC ...
A61K 31/43 (2006.01); A61K 31/424 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2006.01); A61K 47/32 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 9/20 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 9/2095 (2013.01); A61K 31/424 (2013.01); A61K 31/43 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/32 (2013.01);
Abstract

A quick dissolving pharmaceutical formulation is disclosed. In one embodiment, the formulation includes at least the following components: (1) from about 35 to about 50 weight percent amoxicillin or a pharmaceutically acceptable salt thereof; (2) from about 2.0 to about 12 weight percent clavulanic acid or a pharmaceutically acceptable salt thereof; (3) from about 30 to about 40 weight percent mannitol; (4) from about 2 to about 7 weight percent crospovidone; (5) from about 0.5 to about 2.0 weight percent colloidal silicon dioxide; and (6) from about 2.0 to about 5.0 weight percent sodium stearyl fumarate. A method for making a quick dissolving pharmaceutical tablet is also disclosed.

Find Patent Forward Citations

Staric, Rok. (2016). Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid (U.S. Patent No. 9254261). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9254261

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…